Premium
FDA approves first drug therapy for Alzheimer's in 18 years
Author(s) -
Canady Valerie A.
Publication year - 2021
Publication title -
mental health weekly
Language(s) - English
Resource type - Journals
eISSN - 1556-7583
pISSN - 1058-1103
DOI - 10.1002/mhw.32827
Subject(s) - food and drug administration , medicine , drug , pharmacology , psychiatry
The Food and Drug Administration (FDA) last week approved Aduhelm (aducanumab), considered the first novel therapy to be approved for Alzheimer's patients since 2003. The timely and long‐awaited June 8 announcement arrives during National Alzheimer's & Brain Awareness Month.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom